Riluzole vs placeboSevere adverse events attributable to treatment · children with SMA type I1 finding from 1 reviewDrug treatment for spinal muscular atrophy type I 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 10 participantsVery low